Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2012
Coherence brightened laser source for atmospheric remote sensingAndrew J Traverso, Rodrigo Sanchez-Gonzalez, Luqi Yuan, et al.
Future Oncology (London, England)|August 8, 2024
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and SpainIsabel Blancas, Jessica Grosjean, Rebecca Pedersini, et al.
Frontiers in Psychiatry|December 6, 2021
Assessment of Antipsychotic Medications on Social Media: Machine Learning StudyMiguel A Alvarez-Mon, Carolina Donat-Vargas, Javier Santoma-Vilaclara, et al.
Frontiers in Immunology|July 6, 2026
Neonatal CD19<sup>+</sup>B220<sup>lo</sup> cells sense microbiota via TLR2/4 activation driving proliferation and differentiationCarolina Ruiz-Sánchez, Isabel Cortegano, Mercedes Rodríguez, et al.
Annals of Gastroenterology|January 8, 2021
Liver transplantation as last-resort treatment for patients with bile duct injuries following cholecystectomy: a multicenter analysisPeter Tsaparas, Nikolaos Machairas, Victoria Ardiles, et al.
International Journal of Surgery Case Reports|September 2, 2020
Adrenal schwannoma in a female patient; A rare benign neoplasm: Case report and literature reviewMarcos Jafif Cojab, Jesus Flores Armenta, Diego L Jorge, et al.
Frontiers in Immunology|April 11, 2022
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 VaccinationMaria Gonzalez-Perez, Maria Montes-Casado, Patricia Conde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE TrialMaria Vidal, Claudette Falato, Tomás Pascual, et al.
NPJ Breast Cancer|February 10, 2026
Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxaneMarcin Kubeczko, Sandra Cobo, Rodrigo Sanchez-Bayona, et al.
Pageof 8